615-16-7 | 2-Hydroxybenzimidazole

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$6.00	$4.00
10g	98%	in stock	$7.00	$5.00
25g	98%	in stock	$15.00	$11.00
100g	95%	in stock	$28.00	$20.00

Description

• Catalog Number: AI53706
• Chemical Name: 2-Hydroxybenzimidazole
• CAS Number: 615-16-7
• Molecular Formula: C7H6N2O
• Molecular Weight: 134.1353
• MDL Number: MFCD00127894
• SMILES: O=c1[nH]c2c([nH]1)cccc2

Computed Properties

• Complexity: 142
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 2
• XLogP3: 1.1

Literature

• Aza-oxindole synthesis via base promoted Truce-Smiles rearrangement.

  Chemical communications (Cambridge, England) 20121118

• 1-Octyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20120501

• Aza-oxindole synthesis by oxidative coupling of C(sp2)-H and C(sp3)-H centers.

  Chemical communications (Cambridge, England) 20120325

• 1,3-Dibenzyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• 5-Chloro-1-nonyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• 1-Decyl-6-nitro-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• Expanding the repertoire of natural product-inspired ring pairs for molecular recognition of DNA.

  Organic letters 20111021

• Synthesis and Diels-Alder cycloadditions of exo-imidazolidin-2-one dienes.

  The Journal of organic chemistry 20111007

• Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors.

  SAR and QSAR in environmental research 20111001

• 1-Benzyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110701

• Potassium hydroxide/dimethyl sulfoxide promoted intramolecular cyclization for the synthesis of benzimidazol-2-ones.

  Organic letters 20110603

• 1,3-Bis(prop-2-yn-yl)-1H-1,3-benzimid-azol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110501

• 1-Nonyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110201

• 1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110201

• A classification study of respiratory Syncytial Virus (RSV) inhibitors by variable selection with random forest.

  International journal of molecular sciences 20110101

• An inducible expression system of the calcium-activated potassium channel 4 to study the differential impact on embryonic stem cells.

  Stem cells international 20110101

• Isolation and characterization of Pseudomonas sp. CBW capable of degrading carbendazim.

  Biodegradation 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Biodegradation of carbendazim by a novel actinobacterium Rhodococcus jialingiae djl-6-2.

  Chemosphere 20101001

• Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds.

  The journal of physical chemistry. A 20100902

• Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules.

  Journal of medicinal chemistry 20100624

• Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.

  Antiviral research 20100601

• 1-Isopropenyl-1H-1,3-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20100601

• Identification of potent, highly constrained CGRP receptor antagonists.

  Bioorganic & medicinal chemistry letters 20100415

• 1-{[(Cyclo-hexyl-oxy)carbon-yl]-oxy}ethyl 3-{[2'-(2-ethyl-2H-tetra-zol-5-yl)biphenyl-4-yl]meth-yl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20100401

• Rapid access towards follow-up NOP receptor agonists using a knowledge based approach.

  Bioorganic & medicinal chemistry letters 20091115

• 1,3-Bis(hydroxy-meth-yl)benzimidazolin-2-one.

  Acta crystallographica. Section E, Structure reports online 20091101

• 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.

  Journal of medicinal chemistry 20090924

• Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.

  Bioorganic & medicinal chemistry 20090815

• The discovery of highly potent CGRP receptor antagonists.

  Bioorganic & medicinal chemistry letters 20090101

• Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties.

  Bioorganic & medicinal chemistry 20080315

• Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety.

  Bioorganic & medicinal chemistry letters 20070901

• Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.

  Bioorganic & medicinal chemistry letters 20070815

• DFT studies of the structure and vibrational assignments of 4-hydroxy quinazoline and 2-hydroxy benzimidazole.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070401

• Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.

  Bioorganic & medicinal chemistry 20070215

• Benzofused tricycles based on 2-quinoxalinol.

  Journal of combinatorial chemistry 20070101

• Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo.

  Bioorganic & medicinal chemistry letters 20060301

• Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

  Journal of medicinal chemistry 20050505

• Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime).

  Biochimica et biophysica acta 20041011

• Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives.

  Bioorganic & medicinal chemistry letters 20040308

• A theoretical study of substituent effects on tautomerism of 2-hydroxybenzimidazoles.

  Journal of molecular modeling 20031201

• Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognition.

  Journal of the American Chemical Society 20030514

• Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity.

  Bioorganic & medicinal chemistry letters 20020902

• New generation dopaminergic agents. Part 8: heterocyclic bioisosteres that exploit the 7-OH-2-(aminomethyl)chroman D(2) template.

  Bioorganic & medicinal chemistry letters 20020211